Oasis Tears ® PF Preservative-Free Lubricant Eye Drops

Manufacturer: OASIS Medical, Inc. | LABORATOIRE UNITHER COUTANCES
Effective date: 2025-09-12
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-06-01 01:13:49

Label at a glance#

ProductOasis Tears PF Preservative-Free Lubricant Eye

Active ingredientGLYCERIN

Label structure10 sections

Indications and uses

For the temporary relief of burning and irritation due to dryness of the eye For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun For use as a protectant against further irritation or to relieve dryness of the eye

Dosage and administration

Instill 1 or 2 drops in the affected eye(s) as needed.

Storage and handling

protect from light and freezing. store between 41°F (5°C) and 77°F (25°C).

Contacts and useful links#

PhoneLabel contact(800) 631-7180

Websitewww.oasismedical.com

www.oasismedical.com

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Glycerin (0.25%)

Purpose

OTC - PURPOSE SECTION

lubricant Eye Drops

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of burning and irritation due to dryness of the eye
For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun
For use as a protectant against further irritation or to relieve dryness of the eye

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

If solution changes color or becomes cloudy
If you are sensitive to any ingredient in this product

When using this product

OTC - WHEN USING SECTION

To avoid contamination do not touch tip of container to any surface
Replace cap after using
Discard 90 days after opening

Stop use and ask a doctor if

OTC - STOP USE SECTION

You experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Instill 1 or 2 drops in the affected eye(s) as needed.

OTC - QUESTIONS SECTION

Questions, or to report an adverse event call (800) 631-7180 or or log onto www.oasismedical.com

Other Information

STORAGE AND HANDLING SECTION

protect from light and freezing.
store between 41°F (5°C) and 77°F (25°C).

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Sodium hyaluronate, sodium chloride, sodium hydroxide, sodium phosphate dibasic, sodium phosphate monobasic, water

PRINCIPAL DISPLAY PANEL - 10 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

OASIS
TEARS^®

LUBRICANT EYE DROPS
PRESERVATIVE-FREE
STERILE
10mL/0.33FL OZ Bottle

NDC 42126-6400-1

PRINCIPAL DISPLAY PANEL - 10 mL Bottle Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
310541	glycerin 0.25 % Ophthalmic Solution	PSN	8
1598052	Oasis TEARS PF 0.25 % Ophthalmic Solution	PSN	8
1598052	glycerin 2.5 MG/ML Ophthalmic Solution [Oasis Tears]	SBD	8
310541	glycerin 2.5 MG/ML Ophthalmic Solution	SCD	8
310541	glycerin 0.25 % Ophthalmic Solution	SY	8
1598052	Oasis Tears PF 0.25 % Ophthalmic Solution	SY	8

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
GLYCERIN Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
42126-6400-1	Oasis Tears PFPreservative-Free Lubricant Eye	10 mL in 1 BOTTLE, DISPENSING	SOLUTION/ DROPS	10		8
42126-6400-1	Oasis Tears PFPreservative-Free Lubricant Eye	1 in 1 CARTON	SOLUTION/ DROPS	1		8

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Glycerin	ACTIVE INGREDIENT	PDC6A3C0OX	1
Glycerin	ACTIVE MOIETY	PDC6A3C0OX	1
Hyaluronate Sodium	INACTIVE INGREDIENT	YSE9PPT4TH	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	1
Sodium Phosphate, Dibasic	INACTIVE INGREDIENT	GR686LBA74	1
Sodium Phosphate, Monobasic	INACTIVE INGREDIENT	3980JIH2SW	1
Water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Oasis Tears PF Preservative-Free Lubricant Eye
Glycerin
HYALURONATE SODIUM
SODIUM CHLORIDE
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM
SODIUM HYDROXIDE
WATER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
42126-6400	42126-6400-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
GLYCERIN	PDC6A3C0OX	ACTIB
HYALURONATE SODIUM	YSE9PPT4TH	IACT
SODIUM CHLORIDE	451W47IQ8X	IACT
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	3980JIH2SW	IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM	GR686LBA74	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
WATER	059QF0KO0R	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 34 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / OPHTHALMIC	ADJ PH		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAVENOUS		161 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	LOTION / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAMUSCULAR		161 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / TOPICAL	14.2 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Dibasic	SODIUM PHOSPHATE, DIBASIC	GR686LBA74	SUSPENSION / OPHTHALMIC	0.43 %w/w		Exact identifier — unii+route 2 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	0.22 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAVENOUS		161 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAMUSCULAR		161 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SOLUTION / ORAL	25 mg/5ml		Exact identifier — unii candidate 18 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAMUSCULAR		23 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAMUSCULAR		23 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
Sodium Phosphate, Dibasic	SODIUM PHOSPHATE, DIBASIC	GR686LBA74	SUSPENSION / OPHTHALMIC	0.43 %w/w		Exact identifier — unii+route 2 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRA-ARTICULAR		23 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	13.2 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / IONTOPHORESIS	14.2 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / OPHTHALMIC		55 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SOLUTION / ORAL	25 mg/5ml		Exact identifier — unii candidate 18 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	TABLET / ORAL		2 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAVITREAL		23 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	0.22 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	TABLET / ORAL		2 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, SUSPENSION / SUBCUTANEOUS	0.07 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, SUSPENSION / SUBCUTANEOUS	0.07 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / OPHTHALMIC		55 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / OPHTHALMIC	ADJ PH		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRA-ARTICULAR		23 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	LOTION / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	13.2 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / TOPICAL	14.2 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Sodium Phosphate, Monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / IONTOPHORESIS	14.2 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAVITREAL		23 mg	Exact identifier — unii candidate 10 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Oasis Tears PF Preservative-Free Lubricant Eye	GLYCERIN	OASIS Medical, Inc.	640f95f4-c2e8-48ad-ad40-f76bbaddb0dc	2025-09-12	Warnings	Exact identifier ndc (package): 42126-6400-1 ndc (product): 42126-6400 ndc11 (package): 42126640001 spl id: 58c4a89f-c811-462c-a212-fa35c2e46864 spl set id: 640f95f4-c2e8-48ad-ad40-f76bbaddb0dc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.